SCHEMBL21674266

SCHEMBL21674266

c1ccc2oc(-c3ccc(-c4cc(-c5ccc(-c6nc7ccccc7o6)cc5)nc(-c5ccc(-c6nc7ccccc7o6)cc5)n4)cc3)nc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 11/20 0.63
▸ RAB9A P51151 9/20 0.63
▸ MEN1 O00255 3/20 0.63
▸ KMT2A Q03164 3/20 0.63
▸ ATM Q13315 1/20 0.63
▸ MMP2 P08253 1/20 0.59
▸ MMP9 P14780 1/20 0.59
▸ MMP8 P22894 1/20 0.59
▸ MMP13 P45452 1/20 0.59
▸ ALDH1A1 P00352 8/20 0.58
▸ HPGD P15428 7/20 0.58
▸ KDM4E B2RXH2 6/20 0.58
▸ SMN1; SMN2 Q16637 6/20 0.58
▸ HSD17B10 Q99714 5/20 0.58
▸ TP53 P04637 5/20 0.58
▸ MAPT P10636 3/20 0.55
▸ HCRTR1 O43613 2/20 0.51
▸ PKM P14618 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18308629 0.97 NPC1 (0.59) NPC1RAB9AMEN1KMT2AATM
SCHEMBL25895424 0.95 NPC1 (0.58) NPC1RAB9AMEN1KMT2AATM
SCHEMBL25896290 0.95 NPC1 (0.58) NPC1RAB9AMEN1KMT2AATM
SCHEMBL25896084 0.95 NPC1 (0.58) NPC1RAB9AMEN1KMT2AATM
SCHEMBL25304177 0.95 NPC1 (0.58) NPC1RAB9AMEN1KMT2AATM
SCHEMBL23079680 0.92 NPC1 (0.66) NPC1RAB9AMEN1KMT2AATM
SCHEMBL25895430 0.91 NPC1 (0.54) NPC1RAB9AMEN1KMT2AATM
SCHEMBL21674268 0.90 NPC1 (0.77) NPC1RAB9AMEN1KMT2AATM
SCHEMBL23079988 0.90 NPC1 (0.59) NPC1RAB9AMEN1KMT2AATM
SCHEMBL23079708 0.90 NPC1 (0.59) NPC1RAB9AMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129059-A1 PYRIMIDINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2025-04-24 — — US disclosed
EP-4464702-A1 PYRIMIDINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2024-11-20 — — EP disclosed
WO-2023136295-A1 PYRIMIDINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT 保土谷化学工業株式会社 2023-07-20 — — WO disclosed
WO-2023136295-A1 PYRIMIDINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT 保土谷化学工業株式会社 2023-07-20 — — WO disclosed
WO-2020027389-A1 ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME (주)피엔에이치테크 2020-02-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129059-A1 PYRIMIDINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT LEF1, YBX1, YBX3 NPC1 3855/4885RAB9A 3697/4885MEN1 4411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback